pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • NOVOLIN R
    NOVOLIN R (HUMAN INSULIN)
    no indication Novo Nordisk Inc
  • Preclinical
    NOVS-100
    Obesity Celloram Inc
  • NOXAFIL
    NOXAFIL (POSACONAZOLE)
    no indication Merck Sharp & Dohme LLC
  • NOXAFIL POWDERMIX KIT
    NOXAFIL POWDERMIX KIT (POSACONAZOLE)
    neutropenia Merck & Co., Inc.
← prev
page 131 of 271
next →
Pain89
Neurology1
$MRK
  • pre_registration
    NP-001
    Amyotrophic Lateral Sclerosis Neuvivo Inc
  • Phase 3
    NP-028
    Coronavirus Disease 2019 (COVID-19)$EBS Emergent BioSolutions Inc.
  • Phase 1
    NP-10679
    Subarachnoid Hemorrhage NeurOp Inc
  • Phase 2
    NP-213
    Novexatin
    Onychomycosis (Tinea Unguium) Novabiotics Ltd
  • Phase 1
    NP-3
    Nephropathic Cystinosis Nacuity Pharmaceuticals Inc
  • Preclinical
    NP-4
    Cystinosis Nacuity Pharmaceuticals Inc
  • Preclinical
    NP-6A
    Cardiomyopathy Novopyxis Inc
  • Preclinical
    NP-855
    Neuroblastoma NanoPharmaceuticals LLC
  • Preclinical
    NPC-31
    Neurodegenerative Diseases Nobelpharma Co Ltd
  • Phase 3
    NPG-2044
    Ovarian Cancer Novita Pharmaceuticals Inc
  • Phase 1
    NPX-887
    Adenocarcinoma Of The Gastroesophageal Junction NextPoint Therapeutics Inc
  • Preclinical
    NRDN-101
    Type 1 Diabetes (Juvenile Diabetes) Neurodon LLC
  • Phase 1
    NRL-1049
    Cavernous Hemangioma (Cerebral Cavernous Malformation/Cer… Neurelis Inc
  • Phase 1
    NRS-033
    Opium (Opioid) Addiction Nirsum Laboratories Inc
  • Phase 2
    NRT-023
    Post Partum Depression (Maternal Depression / Postnatal D… Nanjing Noratech Pharmaceutical Inc
  • Phase 3
    NRTX-1001
    Epilepsy Neurona Therapeutics Inc
  • Preclinical
    NS-002
    Hyperammonemia Nano Scrips
  • Phase 2
    NS-050
    Duchenne Muscular Dystrophy NS Pharma Inc
  • Preclinical
    NS-051
    Duchenne Muscular Dystrophy NS Pharma Inc
  • Phase 2
    NS-229
    Eosinophilic Granulomatosis with Polyangiitis (Churg-Stra… Nippon Shinyaku Co Ltd
  • Phase 2
    NT-101
    Wet (Neovascular / Exudative) Macular Degeneration NexThera Co Ltd
  • Preclinical
    NT-102
    Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Neuroene Therapeutics LLC
  • Phase 2
    NT-219
    Metastatic Colorectal Cancer$PPBT PURPLE BIOTECH LTD.
  • Phase 2
    NTCDM-3
    Clostridioides difficile Infections (Clostridium difficil… Destiny Pharma Ltd
  • Preclinical
    NTG-101
    Degenerative Disc Disease Notogen Inc
  • Preclinical
    NTM-004
    Pain Neumentum Inc